α7- and α9-Containing Nicotinic Acetylcholine Receptors in the Functioning of Immune System and in Pain
暂无分享,去创建一个
[1] M. Lotz,et al. Human-specific duplicate CHRFAM7A gene is associated with more severe osteoarthritis and amplifies pain behaviours , 2023, Annals of the Rheumatic Diseases.
[2] Ping Zou,et al. Up‐regulation of the human‐specific CHRFAM7A gene protects against renal fibrosis in mice with obstructive nephropathy , 2022, Journal of cellular and molecular medicine.
[3] C. Ghelardini,et al. marine drugs , 2022 .
[4] D. Nolde,et al. Membrane-mediated interaction of non-conventional snake three-finger toxins with nicotinic acetylcholine receptors , 2022, Communications Biology.
[5] J. McIntosh,et al. RgIA4 Prevention of Acute Oxaliplatin-Induced Cold Allodynia Requires α9-Containing Nicotinic Acetylcholine Receptors and CD3+ T-Cells , 2022, Cells.
[6] G. Cymes,et al. An experimental test of the nicotinic hypothesis of COVID-19 , 2022, Proceedings of the National Academy of Sciences of the United States of America.
[7] X. Tian,et al. Targeting α7 nicotinic acetylcholine receptors for chronic pain , 2022, Frontiers in Molecular Neuroscience.
[8] David John Adams,et al. Mechanism of Action and Structure-Activity Relationship of α-Conotoxin Mr1.1 at the Human α9α10 Nicotinic Acetylcholine Receptor. , 2022, Journal of medicinal chemistry.
[9] Chenyun Guo,et al. Discovery and Structural and Functional Characterization of a Novel A-Superfamily Conotoxin Targeting α9α10 Nicotinic Acetylcholine Receptor. , 2022, ACS chemical biology.
[10] K. Candiotti,et al. Mechanism of Electroacupuncture Analgesia on Nicotine Withdrawal-Induced Hyperalgesia in a Rat Model , 2022, Evidence-based complementary and alternative medicine : eCAM.
[11] J. Che,et al. Novel αO-conotoxin GeXIVA[1,2] Nonaddictive Analgesic with Pharmacokinetic Modelling-Based Mechanistic Assessment , 2022, Pharmaceutics.
[12] D. Bertrand,et al. The molecular mechanism of snake short-chain α-neurotoxin binding to muscle-type nicotinic acetylcholine receptors , 2022, Nature Communications.
[13] P. Ling,et al. Tobacco product use and the risks of SARS-CoV-2 infection and COVID-19: current understanding and recommendations for future research , 2022, The Lancet Respiratory Medicine.
[14] Xitong Dang,et al. The emergence of the uniquely human α7 nicotinic acetylcholine receptor gene and its roles in inflammation. , 2022, Gene.
[15] Jing Liu,et al. Preparation of uniform-sized GeXIVA[1,2]-loaded PLGA microspheres as long-effective release system with high encapsulation efficiency , 2022, Drug delivery.
[16] C. Bouzat,et al. A Functional Interaction Between Y674-R685 Region of the SARS-CoV-2 Spike Protein and the Human α7 Nicotinic Receptor , 2022, Molecular Neurobiology.
[17] M. Pallavicini,et al. From 2-Triethylammonium Ethyl Ether of 4-Stilbenol (MG624) to Selective Small-Molecule Antagonists of Human α9α10 Nicotinic Receptor by Modifications at the Ammonium Ethyl Residue , 2022, Journal of medicinal chemistry.
[18] K. Tracey,et al. Manipulation of the inflammatory reflex as a therapeutic strategy , 2022, Cell reports. Medicine.
[19] S. Komisarenko,et al. Immunization with 674–685 fragment of SARS-Cov-2 spike protein induces neuroinflammation and impairs episodic memory of mice , 2022, Biochemical and Biophysical Research Communications.
[20] Matthew S. Jones,et al. Letters to the editor: Nicotinic acetylcholine receptor ligands as potential targets for managing neuropathic pain induced by diabetic peripheral neuropathy , 2022, eNeurologicalSci.
[21] Xiaoxuan Liu,et al. Activation of Cholinergic Anti-Inflammatory Pathway Ameliorates Cerebral and Cardiac Dysfunction After Intracerebral Hemorrhage Through Autophagy , 2022, Frontiers in Immunology.
[22] Dongting Zhangsun,et al. Oligo-basic amino acids, potential nicotinic acetylcholine receptor inhibitors. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[23] F. Berenbaum,et al. Alpha-7 Nicotinic Receptor Dampens Murine Osteoblastic Response to Inflammation and Age-Related Osteoarthritis , 2022, Frontiers in Immunology.
[24] R. Papke,et al. Comparison of the Anti-inflammatory Properties of Two Nicotinic Acetylcholine Receptor Ligands, Phosphocholine and pCF3-diEPP , 2022, Frontiers in Cellular Neuroscience.
[25] D. Fornasari,et al. The Human-Restricted Isoform of the α7 nAChR, CHRFAM7A: A Double-Edged Sword in Neurological and Inflammatory Disorders , 2022, International journal of molecular sciences.
[26] T. Ma,et al. The α7 Nicotinic Acetylcholine Receptor Agonist GTS-21 Improves Bacterial Clearance via Regulation of Monocyte Recruitment and Activity in Polymicrobial Septic Peritonitis , 2022, Frontiers in Immunology.
[27] Y. Tan,et al. Inflammation Regulation via an Agonist and Antagonists of α7 Nicotinic Acetylcholine Receptors in RAW264.7 Macrophages , 2022, Marine drugs.
[28] R. Papke,et al. Selective Agonists and Antagonists of α9 Versus α7 Nicotinic Acetylcholine Receptors. , 2022, ACS chemical neuroscience.
[29] J. Coleman,et al. Structures of highly flexible intracellular domain of human α7 nicotinic acetylcholine receptor , 2022, Nature communications.
[30] O. Kaminuma,et al. Expression and Function of Nicotinic Acetylcholine Receptors in Induced Regulatory T Cells , 2022, International journal of molecular sciences.
[31] Hong Liu,et al. Role of Cholinergic Anti-Inflammatory Pathway in Protecting Sepsis-Induced Acute Lung Injury through Regulation of the Conventional Dendritic Cells , 2022, Mediators of inflammation.
[32] Y. Utkin,et al. Marine Origin Ligands of Nicotinic Receptors: Low Molecular Compounds, Peptides and Proteins for Fundamental Research and Practical Applications , 2022, Biomolecules.
[33] Y. Utkin,et al. α-Conotoxin RgIA and oligoarginine R8 in the mice model alleviate long-term oxaliplatin induced neuropathy. , 2021, Biochimie.
[34] E. Saphire,et al. Structure of the rabies virus glycoprotein trimer bound to a prefusion-specific neutralizing antibody , 2021, bioRxiv.
[35] D. Craik,et al. ɑO‐Conotoxin GeXIVA isomers modulate N‐type calcium (CaV2.2) channels and inwardly‐rectifying potassium (GIRK) channels via GABAB receptor activation , 2021, Journal of Neurochemistry.
[36] M. Munafo,et al. Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort , 2021, Thorax.
[37] R. Papke,et al. Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors , 2021, Pharmacological Reviews.
[38] Johnny J. He,et al. Activation of α7 nicotinic acetylcholine receptor ameliorates HIV-associated neurology and neuropathology , 2021, Brain : a journal of neurology.
[39] J. McIntosh,et al. Discovery of Methylene Thioacetal-Incorporated α-RgIA Analogues as Potent and Stable Antagonists of the Human α9α10 Nicotinic Acetylcholine Receptor for the Treatment of Neuropathic Pain. , 2021, Journal of medicinal chemistry.
[40] J. McIntosh,et al. Selective Penicillamine Substitution Enables Development of a Potent Analgesic Peptide that Acts through a Non-Opioid-Based Mechanism. , 2021, Journal of medicinal chemistry.
[41] David John Adams,et al. Globular and ribbon isomers of Conus geographus α-conotoxins antagonize human nicotinic acetylcholine receptors. , 2021, Biochemical pharmacology.
[42] D. Craik,et al. Engineered Conotoxin Differentially Blocks and Discriminates Rat and Human α7 Nicotinic Acetylcholine Receptors. , 2021, Journal of medicinal chemistry.
[43] S. Bonassi,et al. Nicotine upregulates ACE2 expression and increases competence for SARS-CoV-2 in human pneumocytes , 2021, ERJ Open Research.
[44] U. Gieler,et al. New Pathways for the Skin's Stress Response: The Cholinergic Neuropeptide SLURP-1 Can Activate Mast Cells and Alter Cytokine Production in Mice , 2021, Frontiers in Immunology.
[45] J. Gordon,et al. Regulatory Dendritic Cells, T Cell Tolerance, and Dendritic Cell Therapy for Immunologic Disease , 2021, Frontiers in Immunology.
[46] Hui Zhang,et al. Lyophilization Serves as an Effective Strategy for Drug Development of the α9α10 Nicotinic Acetylcholine Receptor Antagonist α-Conotoxin GeXIVA[1,2] , 2021, Marine drugs.
[47] T. Kuiken,et al. Street RABV Induces the Cholinergic Anti-inflammatory Pathway in Human Monocyte-Derived Macrophages by Binding to nAChr α7 , 2021, Frontiers in Immunology.
[48] Rommie E. Amaro,et al. A potential interaction between the SARS-CoV-2 spike protein and nicotinic acetylcholine receptors , 2021, Biophysical Journal.
[49] K. Farsalinos,et al. Nicotinic cholinergic system and COVID-19: In silico identification of interactions between α7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins , 2021, Food and Chemical Toxicology.
[50] O. Quesada,et al. Disruption of the cholinergic anti-inflammatory response by R5-tropic HIV-1 protein gp120JRFL , 2021, The Journal of biological chemistry.
[51] A. Chávez-Reyes,et al. The human-specific duplicated α7 gene inhibits the ancestral α7, negatively regulating nicotinic acetylcholine receptor-mediated transmitter release , 2021, The Journal of biological chemistry.
[52] V. Lemos,et al. Role of the α7 Nicotinic Acetylcholine Receptor in the Pathophysiology of Atherosclerosis , 2020, Frontiers in Physiology.
[53] K. Mineev,et al. Spatial Structure and Activity of Synthetic Fragments of Lynx1 and of Nicotinic Receptor Loop C Models , 2020, Biomolecules.
[54] Yan-yan Chu,et al. Medicinal chemistry, pharmacology, and therapeutic potential of α-conotoxins antagonizing the α9α10 nicotinic acetylcholine receptor. , 2020, Pharmacology & therapeutics.
[55] I. Tikhonova,et al. α9α10 nicotinic acetylcholine receptors regulate murine bone marrow granulocyte functions. , 2020, Immunobiology.
[56] R. Lewis,et al. Structure-Function of Neuronal Nicotinic Acetylcholine Receptor Inhibitors Derived From Natural Toxins , 2020, Frontiers in Neuroscience.
[57] M. Kirpichnikov,et al. Structural Diversity and Dynamics of Human Three-Finger Proteins Acting on Nicotinic Acetylcholine Receptors , 2020, International journal of molecular sciences.
[58] Georgios E. Papadopoulos,et al. Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications , 2020, International journal of molecular sciences.
[59] Y. Utkin,et al. Three‐finger proteins from snakes and humans acting on nicotinic receptors: Old and new , 2020, Journal of neurochemistry.
[60] M. Kloc,et al. How nicotine can inhibit cytokine storm in the lungs and prevent or lessen the severity of COVID-19 infection? , 2020, Immunology Letters.
[61] J. McIntosh,et al. Behavioral and Molecular Basis of Cholinergic Modulation of Pain: Focus on Nicotinic Acetylcholine Receptors. , 2020, Current topics in behavioral neurosciences.
[62] Y. Qadri,et al. Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19 , 2020, Journal of Cardiovascular Translational Research.
[63] M. Motaghinejad,et al. Survival of COVID-19 patients requires precise immune regulation: The hypothetical immunoprotective role of nicotinic agonists , 2020, Medical Hypotheses.
[64] K. Farsalinos,et al. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? , 2020, Internal and Emergency Medicine.
[65] K. Sałat. Chemotherapy-induced peripheral neuropathy—part 2: focus on the prevention of oxaliplatin-induced neurotoxicity , 2020, Pharmacological Reports.
[66] Patrizia Russo,et al. COVID-19 and smoking: is nicotine the hidden link? , 2020, European Respiratory Journal.
[67] J. Changeux,et al. A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications. , 2020, Comptes rendus biologies.
[68] A. Karlin,et al. Structure of the Native Muscle-type Nicotinic Receptor and Inhibition by Snake Venom Toxins , 2020, Neuron.
[69] P. Balaban,et al. Water‐soluble variant of human Lynx1 positively modulates synaptic plasticity and ameliorates cognitive impairment associated with α7‐nAChR dysfunction , 2020, Journal of neurochemistry.
[70] Y. Utkin,et al. Activation of α7 Nicotinic Acetylcholine Receptor Upregulates HLA-DR and Macrophage Receptors: Potential Role in Adaptive Immunity and in Preventing Immunosuppression , 2020, Biomolecules.
[71] M. Kirpichnikov,et al. Human secreted protein SLURP-1 abolishes nicotine-induced proliferation, PTEN down-regulation and α7-nAChR expression up-regulation in lung cancer cells. , 2020, International immunopharmacology.
[72] K. Kawashima,et al. α7 nAChRs expressed on antigen presenting cells are insensitive to the conventional antagonists α-bungarotoxin and methyllycaconitine. , 2020, International Immunopharmacology.
[73] J. McIntosh,et al. RgIA4 Accelerates Recovery from Paclitaxel-Induced Neuropathic Pain in Rats , 2019, Marine drugs.
[74] W. D. de Jonge,et al. Acetylcholine-producing T-cells augment innate immune driven colitis but are redundant in T-cell driven colitis. , 2019, American journal of physiology. Gastrointestinal and liver physiology.
[75] Jie Zhang,et al. Migration of gastric cancer is suppressed by recombinant Newcastle disease virus (rL-RVG) via regulating α7-nicotinic acetylcholine receptors/ERK- EMT , 2019, BMC Cancer.
[76] D. Craik,et al. Conotoxins: Chemistry and Biology. , 2019, Chemical reviews.
[77] J. Ecklund,et al. Association of a Functional Polymorphism in the CHRFAM7A Gene with Inflammatory Response Mediators and Neuropathic Pain after Spinal Cord Injury. , 2019, Journal of neurotrauma.
[78] N. Staff,et al. Platinum‐induced peripheral neurotoxicity: From pathogenesis to treatment , 2019, Journal of the peripheral nervous system : JPNS.
[79] Anil Tiwari,et al. The secreted Ly-6/uPAR related protein-1 (SLURP1) stabilizes epithelial cell junctions and suppresses TNF-α-induced cytokine production. , 2019, Biochemical and biophysical research communications.
[80] David John Adams,et al. α-Conotoxin Vc1.1 Structure-Activity Relationship at the Human α9α10 Nicotinic Acetylcholine Receptor Investigated by Minimal Side Chain Replacement. , 2019, ACS chemical neuroscience.
[81] Y. Utkin,et al. From Synthetic Fragments of Endogenous Three-Finger Proteins to Potential Drugs , 2019, Front. Pharmacol..
[82] D. Fornasari,et al. Effect of donepezil on the expression and responsiveness to LPS of CHRNA7 and CHRFAM7A in macrophages: A possible link to the cholinergic anti-inflammatory pathway , 2019, Journal of Neuroimmunology.
[83] K. Kawashima,et al. Distinct Roles of α7 nAChRs in Antigen-Presenting Cells and CD4+ T Cells in the Regulation of T Cell Differentiation , 2019, Front. Immunol..
[84] R. Su,et al. The α9α10 Nicotinic Acetylcholine Receptor Antagonist αO-Conotoxin GeXIVA[1,2] Alleviates and Reverses Chemotherapy-Induced Neuropathic Pain , 2019, Marine drugs.
[85] V. Tsetlin,et al. Crystal Structure of the Monomeric Extracellular Domain of α9 Nicotinic Receptor Subunit in Complex With α-Conotoxin RgIA: Molecular Dynamics Insights Into RgIA Binding to α9α10 Nicotinic Receptors , 2019, Front. Pharmacol..
[86] J. Miwa,et al. Lynx Prototoxins: Roles of Endogenous Mammalian Neurotoxin-Like Proteins in Modulating Nicotinic Acetylcholine Receptor Function to Influence Complex Biological Processes , 2019, Front. Pharmacol..
[87] G. Upadhyay. Emerging Role of Lymphocyte Antigen-6 Family of Genes in Cancer and Immune Cells , 2019, Front. Immunol..
[88] V. Jhanji,et al. The secreted Ly6/uPAR-related protein-1 suppresses neutrophil binding, chemotaxis, and transmigration through human umbilical vein endothelial cells , 2019, Scientific Reports.
[89] J. McIntosh,et al. Conopeptides [V11L;V16D]ArIB and RgIA4: Powerful Tools for the Identification of Novel Nicotinic Acetylcholine Receptors in Monocytes , 2019, Front. Pharmacol..
[90] T. Deer,et al. Intrathecal Therapy for Chronic Pain: A Review of Morphine and Ziconotide as Firstline Options , 2018, Pain medicine.
[91] R. Katsarava,et al. Oligoarginine Peptides, a New Family of nAChR Inhibitors. , 2019, Molecular Pharmacology.
[92] Hui Luo,et al. The effect of the cholinergic anti-inflammatory pathway on collagen-induced arthritis involves the modulation of dendritic cell differentiation , 2018, Arthritis Research & Therapy.
[93] Michael A. Faltys,et al. Adenylyl Cyclase 6 Mediates Inhibition of TNF in the Inflammatory Reflex , 2018, Front. Immunol..
[94] V. Tsetlin,et al. Species specificity of rat and human α7 nicotinic acetylcholine receptors towards different classes of peptide and protein antagonists , 2018, Neuropharmacology.
[95] R. Papke,et al. The Antinociceptive and Anti-Inflammatory Properties of the α7 nAChR Weak Partial Agonist p-CF3 N,N-diethyl-N′-phenylpiperazine , 2018, The Journal of Pharmacology and Experimental Therapeutics.
[96] W. Padberg,et al. Phosphocholine-Modified Lipooligosaccharides of Haemophilus influenzae Inhibit ATP-Induced IL-1β Release by Pulmonary Epithelial Cells , 2018, Molecules.
[97] I. König,et al. C-Reactive Protein Stimulates Nicotinic Acetylcholine Receptors to Control ATP-Mediated Monocytic Inflammasome Activation , 2018, Front. Immunol..
[98] J. Lasalde-Dominicci,et al. Nicotinic Acetylcholine Receptors in HIV: Possible Roles During HAND and Inflammation , 2018, Cellular and Molecular Neurobiology.
[99] W. Im,et al. Augmenting the antinociceptive effects of nicotinic acetylcholine receptor activity through lynx1 modulation , 2018, PloS one.
[100] R. Lewis,et al. Neuronal Nicotinic Acetylcholine Receptor Modulators from Cone Snails , 2018, Marine drugs.
[101] C. Enjalbal,et al. Synthesis, Structure and Biological Activity of CIA and CIB, Two α-Conotoxins from the Predation-Evoked Venom of Conus catus , 2018, Toxins.
[102] P. Dougherty,et al. Beyond symptomatic relief for chemotherapy‐induced peripheral neuropathy: Targeting the source , 2018, Cancer.
[103] D. Servent,et al. α9‐containing nicotinic acetylcholine receptors and the modulation of pain , 2018, British journal of pharmacology.
[104] M. Skok,et al. α7 nicotinic acetylcholine receptors are involved in suppression of the antibody immune response , 2018, Journal of Neuroimmunology.
[105] J. Lasalde-Dominicci,et al. The Cholinergic Anti-Inflammatory Response and the Role of Macrophages in HIV-Induced Inflammation , 2018, International journal of molecular sciences.
[106] R. Nichols,et al. Beyond the Channel: Metabotropic Signaling by Nicotinic Receptors. , 2018, Trends in pharmacological sciences.
[107] D. Dolgikh,et al. Human secreted proteins SLURP‐1 and SLURP‐2 control the growth of epithelial cancer cells via interactions with nicotinic acetylcholine receptors , 2018, British journal of pharmacology.
[108] K. Felix,et al. Endogenous CHRNA7-ligand SLURP1 as a potential tumor suppressor and anti-nicotinic factor in pancreatic cancer , 2018, Oncotarget.
[109] D. Craik,et al. Interaction of Synthetic Human SLURP-1 with the Nicotinic Acetylcholine Receptors , 2017, Scientific Reports.
[110] R. Papke,et al. Rabies virus modifies host behaviour through a snake-toxin like region of its glycoprotein that inhibits neurotransmitter receptors in the CNS , 2017, Scientific Reports.
[111] P. Keating,et al. Effects of α-conotoxin ImI on TNF-α, IL-8 and TGF-β expression by human macrophage-like cells derived from THP-1 pre-monocytic leukemic cells , 2017, Scientific Reports.
[112] K. Kawashima,et al. Expression and Function of the Cholinergic System in Immune Cells , 2017, Front. Immunol..
[113] Shuo Yu,et al. Cloning, expression and functional characterization of a D-superfamily conotoxin Lt28.1 with previously undescribed cysteine pattern , 2017, Peptides.
[114] E. Glowatzki,et al. RgIA4 Potently Blocks Mouse α9α10 nAChRs and Provides Long Lasting Protection against Oxaliplatin-Induced Cold Allodynia , 2017, Front. Cell. Neurosci..
[115] F. Shi,et al. Acetylcholine-producing NK cells attenuate CNS inflammation via modulation of infiltrating monocytes/macrophages , 2017, Proceedings of the National Academy of Sciences.
[116] W. Padberg,et al. Canonical and Novel Non-Canonical Cholinergic Agonists Inhibit ATP-Induced Release of Monocytic Interleukin-1β via Different Combinations of Nicotinic Acetylcholine Receptor Subunits α7, α9 and α10 , 2017, Front. Cell. Neurosci..
[117] C. Zhao,et al. Monocytes primed with GTS-21/&agr;7 nAChR (nicotinic acetylcholine receptor) agonist develop anti-inflammatory memory , 2017, QJM : monthly journal of the Association of Physicians.
[118] David John Adams,et al. Identification of a Novel O-Conotoxin Reveals an Unusual and Potent Inhibitor of the Human α9α10 Nicotinic Acetylcholine Receptor , 2017, Marine drugs.
[119] C. Ruppert,et al. Surfactant inhibits ATP-induced release of interleukin-1β via nicotinic acetylcholine receptors[S] , 2017, Journal of Lipid Research.
[120] K. Kawashima,et al. Physiological functions of the cholinergic system in immune cells. , 2017, Journal of pharmacological sciences.
[121] C. Ghelardini,et al. Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain , 2017, Proceedings of the National Academy of Sciences.
[122] S. Im,et al. Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer , 2017, Supportive Care in Cancer.
[123] A. Ceballos,et al. Acetylcholine polarizes dendritic cells toward a Th2‐promoting profile , 2017, Allergy.
[124] N. Knuckey,et al. The Neuroprotective Peptide Poly-Arginine-12 (R12) Reduces Cell Surface Levels of NMDA NR2B Receptor Subunit in Cortical Neurons; Investigation into the Involvement of Endocytic Mechanisms , 2016, Journal of Molecular Neuroscience.
[125] R. Efremov,et al. High-Affinity α-Conotoxin PnIA Analogs Designed on the Basis of the Protein Surface Topography Method , 2016, Scientific Reports.
[126] P. Thompson,et al. Nicotine induces neutrophil extracellular traps , 2016, Journal of leukocyte biology.
[127] Mengsen Li,et al. Residues Responsible for the Selectivity of α-Conotoxins for Ac-AChBP or nAChRs , 2016, Marine drugs.
[128] C. Ghelardini,et al. The α9α10 nicotinic receptor antagonist α-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment , 2016, Experimental Neurology.
[129] V. N. Mal'tseva,et al. Nicotinic receptor involvement in regulation of functions of mouse neutrophils from inflammatory site. , 2016, Immunobiology.
[130] W. Padberg,et al. Phosphocholine – an agonist of metabotropic but not of ionotropic functions of α9-containing nicotinic acetylcholine receptors , 2016, Scientific Reports.
[131] C. Bouzat,et al. Expression and Functional Role of α7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) Cells* , 2016, The Journal of Biological Chemistry.
[132] D. Craik,et al. Structure-Activity Studies of Cysteine-Rich α-Conotoxins that Inhibit High-Voltage-Activated Calcium Channels via GABA(B) Receptor Activation Reveal a Minimal Functional Motif. , 2016, Angewandte Chemie.
[133] Dongting Zhangsun,et al. Anti-hypersensitive effect of intramuscular administration of αO-conotoxin GeXIVA[1,2] and GeXIVA[1,4] in rats of neuropathic pain , 2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[134] J. Hao,et al. Infiltration of CCR2+Ly6Chigh Proinflammatory Monocytes and Neutrophils into the Central Nervous System Is Modulated by Nicotinic Acetylcholine Receptors in a Model of Multiple Sclerosis , 2016, The Journal of Immunology.
[135] J. Hao,et al. Nicotinic Acetylcholine Receptors Modulate Bone Marrow-Derived Pro-Inflammatory Monocyte Production and Survival , 2016, PloS one.
[136] D. Dolgikh,et al. Human Secreted Ly-6/uPAR Related Protein-1 (SLURP-1) Is a Selective Allosteric Antagonist of α7 Nicotinic Acetylcholine Receptor , 2016, PloS one.
[137] R. Coimbra,et al. Up-regulation of the human-specific CHRFAM7A gene in inflammatory bowel disease , 2016, BBA clinical.
[138] J. Lasalde-Dominicci,et al. The α7-nicotinic receptor is upregulated in immune cells from HIV-seropositive women: consequences to the cholinergic anti-inflammatory response , 2015, Clinical & translational immunology.
[139] K. Kawashima,et al. Non-neuronal cholinergic system in regulation of immune function with a focus on α7 nAChRs. , 2015, International immunopharmacology.
[140] M. Christie,et al. Conotoxin Interactions with α9α10-nAChRs: Is the α9α10-Nicotinic Acetylcholine Receptor an Important Therapeutic Target for Pain Management? , 2015, Toxins.
[141] W. Padberg,et al. Phosphocholine-Modified Macromolecules and Canonical Nicotinic Agonists Inhibit ATP-Induced IL-1β Release , 2015, The Journal of Immunology.
[142] J. McIntosh,et al. αS-conotoxin GVIIIB potently and selectively blocks α9α10 nicotinic acetylcholine receptors. , 2015, Biochemical pharmacology.
[143] D. Craik,et al. Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist , 2015, Proceedings of the National Academy of Sciences.
[144] W. Zang,et al. Acetylcholine Inhibits LPS-Induced MMP-9 Production and Cell Migration via the a7 nAChR-JAK2/STAT3 Pathway in RAW264.7 Cells , 2015, Cellular Physiology and Biochemistry.
[145] Qiuyun Dai,et al. Structural and Functional Characterization of a Novel α-Conotoxin Mr1.7 from Conus marmoreus Targeting Neuronal nAChR α3β2, α9α10 and α6/α3β2β3 Subtypes , 2015, Marine drugs.
[146] V. Tsetlin. Three-finger snake neurotoxins and Ly6 proteins targeting nicotinic acetylcholine receptors: pharmacological tools and endogenous modulators. , 2015, Trends in pharmacological sciences.
[147] M. Nouri-Shirazi,et al. Nicotine Exposure Alters the mRNA Expression of Notch Ligands in Dendritic Cells and Their Response to Th1‐/Th2‐Promoting Stimuli , 2015, Scandinavian journal of immunology.
[148] David John Adams,et al. Novel Mechanism of Voltage-Gated N-type (Cav2.2) Calcium Channel Inhibition Revealed through α-Conotoxin Vc1.1 Activation of the GABAB Receptor , 2015, Molecular Pharmacology.
[149] Andrew B. Wright,et al. Limited Efficacy of α-Conopeptides, Vc1.1 and RgIA, To Inhibit Sensory Neuron CaV Current,, , 2015, eNeuro.
[150] W. Kummer,et al. Functional expression and axonal transport of α7 nAChRs by peptidergic nociceptors of rat dorsal root ganglion , 2015, Brain Structure and Function.
[151] J. L. Le Caer,et al. Isolation, purification and functional characterization of alpha-BnIA from Conus bandanus venom. , 2014, Toxicon : official journal of the International Society on Toxinology.
[152] P. Herdewijn,et al. Discovery of a new subclass of α-conotoxins in the venom of Conus australis. , 2014, Toxicon : official journal of the International Society on Toxinology.
[153] M. J. McIntosh,et al. α-Conotoxin RgIA protects against the development of nerve injury-induced chronic pain and prevents both neuronal and glial derangement , 2014, PAIN®.
[154] H. Lester,et al. The Duplicated α7 Subunits Assemble and Form Functional Nicotinic Receptors with the Full-length α7* , 2014, The Journal of Biological Chemistry.
[155] S. Grando,et al. Anti-Inflammatory Effects of the Nicotinergic Peptides SLURP-1 and SLURP-2 on Human Intestinal Epithelial Cells and Immunocytes , 2014, BioMed research international.
[156] J. Tytgat,et al. Conotoxins Targeting Nicotinic Acetylcholine Receptors: An Overview , 2014, Marine drugs.
[157] D. Craik,et al. Discovery, synthesis, and structure-activity relationships of conotoxins. , 2014, Chemical reviews.
[158] H. Sunaga,et al. SLURP-1, an endogenous α7 nicotinic acetylcholine receptor allosteric ligand, is expressed in CD205+ dendritic cells in human tonsils and potentiates lymphocytic cholinergic activity , 2014, Journal of Neuroimmunology.
[159] I. Vetter,et al. MrIC, a novel α-conotoxin agonist in the presence of PNU at endogenous α7 nicotinic acetylcholine receptors. , 2014, Biochemistry.
[160] M. Christie,et al. α9-nicotinic acetylcholine receptors contribute to the maintenance of chronic mechanical hyperalgesia, but not thermal or mechanical allodynia , 2014, Molecular pain.
[161] P. Herdewijn,et al. Structure-Function Elucidation of a New α-Conotoxin, Lo1a, from Conus longurionis , 2013, The Journal of Biological Chemistry.
[162] D. Craik,et al. Isolation and characterization of α-conotoxin LsIA with potent activity at nicotinic acetylcholine receptors. , 2013, Biochemical pharmacology.
[163] R. Norton,et al. Dicarba α-conotoxin Vc1.1 analogues with differential selectivity for nicotinic acetylcholine and GABAB receptors. , 2013, ACS chemical biology.
[164] D. Craik,et al. Determination of the α-conotoxin Vc1.1 binding site on the α9α10 nicotinic acetylcholine receptor. , 2013, Journal of medicinal chemistry.
[165] F. Shi,et al. Nicotinic Receptor β2 Determines NK Cell-Dependent Metastasis in a Murine Model of Metastatic Lung Cancer , 2013, PloS one.
[166] T. Mak,et al. Lymphocyte-derived ACh regulates local innate but not adaptive immunity , 2013, Proceedings of the National Academy of Sciences.
[167] L. Azam,et al. Molecular basis for the differential sensitivity of rat and human α9α10 nAChRs to α‐conotoxin RgIA , 2012, Journal of neurochemistry.
[168] David John Adams,et al. Intrathecal α-conotoxins Vc1.1, AuIB and MII acting on distinct nicotinic receptor subtypes reverse signs of neuropathic pain , 2012, Neuropharmacology.
[169] David John Adams,et al. γ-Aminobutyric Acid Type B (GABAB) Receptor Expression Is Needed for Inhibition of N-type (Cav2.2) Calcium Channels by Analgesic α-Conotoxins* , 2012, The Journal of Biological Chemistry.
[170] David John Adams,et al. Analgesic conotoxins: block and G protein‐coupled receptor modulation of N‐type (CaV2.2) calcium channels , 2012, British journal of pharmacology.
[171] E. P. van der Zanden,et al. Nicotinic Acetylcholine Receptor Expression and Susceptibility to Cholinergic Immunomodulation in Human Monocytes of Smoking Individuals , 2012, Neuroimmunomodulation.
[172] D. Craik,et al. RegIIA: an α4/7-conotoxin from the venom of Conus regius that potently blocks α3β4 nAChRs. , 2012, Biochemical pharmacology.
[173] D. Palange,et al. β2‐Adrenoreceptors of regulatory lymphocytes are essential for vagal neuromodulation of the innate immune system , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[174] L. Dwoskin,et al. The novel small molecule α9α10 nicotinic acetylcholine receptor antagonist ZZ-204G is analgesic. , 2011, European journal of pharmacology.
[175] D. Bertrand,et al. The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR function. , 2011, Biochemical pharmacology.
[176] Tak W. Mak,et al. Acetylcholine-Synthesizing T Cells Relay Neural Signals in a Vagus Nerve Circuit , 2011, Science.
[177] V. Tsetlin,et al. Design of New α-Conotoxins: From Computer Modeling to Synthesis of Potent Cholinergic Compounds , 2011, Marine drugs.
[178] H. Kurzen,et al. The cholinergic system in guttate psoriasis with special reference to mast cells , 2011, Experimental dermatology.
[179] R. Norton,et al. Embryonic Toxin Expression in the Cone Snail Conus victoriae , 2011, The Journal of Biological Chemistry.
[180] E. Deitch,et al. α7-Cholinergic Receptor Mediates Vagal Induction of Splenic Norepinephrine , 2011, The Journal of Immunology.
[181] V. Tsetlin,et al. Assembly of nicotinic and other Cys‐loop receptors , 2011, Journal of neurochemistry.
[182] D. Craik,et al. Structure and Activity of α-Conotoxin PeIA at Nicotinic Acetylcholine Receptor Subtypes and GABAB Receptor-coupled N-type Calcium Channels* , 2011, The Journal of Biological Chemistry.
[183] D. Bertrand,et al. NMR Structure and Action on Nicotinic Acetylcholine Receptors of Water-soluble Domain of Human LYNX1* , 2011, The Journal of Biological Chemistry.
[184] J. Renart,et al. Function of partially duplicated human α77 nicotinic receptor subunit CHRFAM7A gene: potential implications for the cholinergic anti-inflammatory response. , 2011, The Journal of biological chemistry.
[185] Yong-ming Yao,et al. Stimulation of α7 Nicotinic Acetylcholine Receptor by Nicotine Increases Suppressive Capacity of Naturally Occurring CD4+CD25+ Regulatory T Cells in Mice In Vitro , 2010, Journal of Pharmacology and Experimental Therapeutics.
[186] P. Whiteaker,et al. Alexa Fluor 546‐ArIB[V11L;V16A] is a potent ligand for selectively labeling α7 nicotinic acetylcholine receptors , 2010, Journal of neurochemistry.
[187] R. Langley,et al. Nicotine Inhibits FcεRI-Induced Cysteinyl Leukotrienes and Cytokine Production without Affecting Mast Cell Degranulation Through α7/α9/α10-Nicotinic Receptors , 2010, The Journal of Immunology.
[188] S. Grando,et al. Auto/paracrine control of inflammatory cytokines by acetylcholine in macrophage-like U937 cells through nicotinic receptors. , 2010, International immunopharmacology.
[189] S. Baksh,et al. Nicotine-mediated signals modulate cell death and survival of T lymphocytes. , 2010, Toxicology and applied pharmacology.
[190] David John Adams,et al. Analgesic α-conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in sensory neurons of α9 nicotinic receptor knockout mice , 2010, Channels.
[191] N. Parameswaran,et al. Tumor necrosis factor-α signaling in macrophages. , 2010, Critical reviews in eukaryotic gene expression.
[192] A. Malik,et al. Requisite Role of the Cholinergic α7 Nicotinic Acetylcholine Receptor Pathway in Suppressing Gram-Negative Sepsis-Induced Acute Lung Inflammatory Injury , 2009, The Journal of Immunology.
[193] A. Orr-Urtreger,et al. Activation of the Cholinergic Anti-Inflammatory System by Nicotine Attenuates Neuroinflammation via Suppression of Th1 and Th17 Responses , 2009, The Journal of Immunology.
[194] Richard A Houghten,et al. A Synthetic Combinatorial Strategy for Developing α-Conotoxin Analogs as Potent α7 Nicotinic Acetylcholine Receptor Antagonists* , 2009, The Journal of Biological Chemistry.
[195] N. Absalom,et al. Alpha9 nicotinic acetylcholine receptors and the treatment of pain. , 2009, Biochemical pharmacology.
[196] Natsuko Kageyama-Yahara,et al. IgE-induced degranulation of mucosal mast cells is negatively regulated via nicotinic acetylcholine receptors. , 2008, Biochemical and biophysical research communications.
[197] Alison Haythornthwaite,et al. Analgesic α-Conotoxins Vc1.1 and Rg1A Inhibit N-Type Calcium Channels in Rat Sensory Neurons via GABAB Receptor Activation , 2008, The Journal of Neuroscience.
[198] Kevin J. Tracey,et al. Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia , 2008, Proceedings of the National Academy of Sciences.
[199] S. Wonnacott,et al. αConotoxin Arenatus IB[V11L,V16D] Is a Potent and Selective Antagonist at Rat and Human Native α7 Nicotinic Acetylcholine Receptors , 2008, Journal of Pharmacology and Experimental Therapeutics.
[200] Eric Vivier,et al. Functions of natural killer cells , 2008, Nature Immunology.
[201] A. Collins,et al. Synthesis and Characterization of 125I-α-Conotoxin ArIB[V11L;V16A], a Selective α7 Nicotinic Acetylcholine Receptor Antagonist , 2008, Journal of Pharmacology and Experimental Therapeutics.
[202] D. Craik,et al. Are α9α10 Nicotinic Acetylcholine Receptors a Pain Target for α-Conotoxins? , 2007, Molecular Pharmacology.
[203] K. Kawashima,et al. Enhanced serum antigen-specific IgG1 and proinflammatory cytokine production in nicotinic acetylcholine receptor α7 subunit gene knockout mice , 2007, Journal of Neuroimmunology.
[204] H. Kurzen,et al. Nicotinic receptors on rat alveolar macrophages dampen ATP-induced increase in cytosolic calcium concentration , 2007, Autonomic Neuroscience.
[205] J. McIntosh,et al. Targeting the α9α10 nicotinic acetylcholine receptor to treat severe pain , 2007 .
[206] T. van der Poll,et al. LOCAL STIMULATION OF α7 CHOLINERGIC RECEPTORS INHIBITS LPS-INDUCED TNF-α RELEASE IN THE MOUSE LUNG , 2007, Shock.
[207] J. Changeux,et al. The role of nicotinic receptors in B-lymphocyte development and activation. , 2007, Life sciences.
[208] D. Yoshikami,et al. Discovery, synthesis, and structure activity of a highly selective alpha7 nicotinic acetylcholine receptor antagonist. , 2007, Biochemistry.
[209] M. Matthay,et al. Activation of the α7 nAChR Reduces Acid-Induced Acute Lung Injury in Mice and Rats , 2007 .
[210] M. Dolan,et al. Molecular mechanisms of resistance and toxicity associated with platinating agents. , 2007, Cancer treatment reviews.
[211] P. Williams,et al. Nicotinic acetylcholine receptors on basophils and mast cells , 2006, Anaesthesia.
[212] T. Yoshino,et al. Effect of nicotine on IL‐18‐initiated immune response in human monocytes , 2006, Journal of leukocyte biology.
[213] J. McIntosh,et al. Molecular mechanism for analgesia involving specific antagonism of α9α10 nicotinic acetylcholine receptors , 2006, Proceedings of the National Academy of Sciences.
[214] P. Sansonetti. The innate signaling of dangers and the dangers of innate signaling , 2006, Nature Immunology.
[215] Igor Tsigelny,et al. α-Conotoxin OmIA Is a Potent Ligand for the Acetylcholine-binding Protein as Well as α3β2 and α7 Nicotinic Acetylcholine Receptors* , 2006, Journal of Biological Chemistry.
[216] D. Craik,et al. The Synthesis, Structural Characterization, and Receptor Specificity of the α-Conotoxin Vc1.1* , 2006, Journal of Biological Chemistry.
[217] D. Tracey,et al. Immune and inflammatory mechanisms in neuropathic pain , 2006, Brain Research Reviews.
[218] V. Pavlov,et al. Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis , 2006, The Journal of experimental medicine.
[219] J. McIntosh,et al. α-RgIA: A Novel Conotoxin That Specifically and Potently Blocks the α9α10 nAChR†,‡ , 2006 .
[220] J. Changeux,et al. The role of nicotinic acetylcholine receptors in lymphocyte development , 2006, Journal of Neuroimmunology.
[221] T. Yoshino,et al. alpha7 Nicotinic acetylcholine receptor stimulation inhibits lipopolysaccharide-induced interleukin-18 and -12 production in monocytes. , 2006, Journal of pharmacological sciences.
[222] K. Gayler,et al. Alpha-conotoxin Vc1.1 alleviates neuropathic pain and accelerates functional recovery of injured neurones , 2005, Brain Research.
[223] C. Dejong,et al. Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve , 2005, The Journal of experimental medicine.
[224] S. Kracun,et al. Effects of Quinine, Quinidine, and Chloroquine on α9α10 Nicotinic Cholinergic Receptors , 2005, Molecular Pharmacology.
[225] J. McIntosh,et al. A Novel α-Conotoxin, PeIA, Cloned from Conus pergrandis, Discriminates between Rat α9α10 and α7 Nicotinic Cholinergic Receptors* , 2005, Journal of Biological Chemistry.
[226] Jian-Lan Jiang,et al. [Effect of acetylcholine on the cytotoxicity of natural killer cells]. , 2005, Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology.
[227] H. Berthoud,et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway , 2005, Nature Immunology.
[228] J. Changeux,et al. Nicotinic receptors regulate B lymphocyte activation and immune response. , 2005, European journal of pharmacology.
[229] N. Unwin,et al. Refined structure of the nicotinic acetylcholine receptor at 4A resolution. , 2005, Journal of molecular biology.
[230] M. Rustici,et al. Sequence homology between HIV gp120, rabies virus glycoprotein, and snake venom neurotoxins , 2005, Archives of Virology.
[231] S. Sine,et al. α-Conotoxins ImI and ImII target distinct regions of the human α7 nicotinic acetylcholine receptor and distinguish human nicotinic receptor subtypes , 2004 .
[232] R. Ferris,et al. Characterization of the human nicotinic acetylcholine receptor subunit alpha (alpha) 9 (CHRNA9) and alpha (alpha) 10 (CHRNA10) in lymphocytes. , 2004, Life sciences.
[233] David John Adams,et al. Chemical and functional identification and characterization of novel sulfated alpha-conotoxins from the cone snail Conus anemone. , 2004, Journal of medicinal chemistry.
[234] Laure Plantard,et al. Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda. , 2003, Human molecular genetics.
[235] A. Maelicke,et al. α‐Conotoxins EpI and AuIB switch subtype selectivity and activity in native versus recombinant nicotinic acetylcholine receptors , 2003 .
[236] M. Nouri-Shirazi,et al. Evidence for the immunosuppressive role of nicotine on human dendritic cell functions , 2003, Immunology.
[237] N. Hogg. Nicotine has suppressive effects on dendritic cell function , 2003, Immunology.
[238] P. Gopalakrishnakone,et al. Non-conventional toxins from Elapid venoms. , 2003, Toxicon : official journal of the International Society on Toxinology.
[239] D. Craik,et al. Isolation, Structure, and Activity of GID, a Novel α4/7-Conotoxin with an Extended N-terminal Sequence* , 2003, The Journal of Biological Chemistry.
[240] J. McIntosh,et al. α-Conotoxins ImI and ImII , 2003, The Journal of Biological Chemistry.
[241] Kevin J. Tracey,et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation , 2002, Nature.
[242] Kevin J. Tracey,et al. The inflammatory reflex , 2002, Nature.
[243] W. Kummer,et al. Coexpression of α9 and α10 nicotinic acetylcholine receptors in rat dorsal root ganglion neurons , 2002, Neuroscience.
[244] T. Sixma,et al. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors , 2001, Nature.
[245] D Bertrand,et al. “Weak Toxin” from Naja kaouthia Is a Nontoxic Antagonist of α7 and Muscle-type Nicotinic Acetylcholine Receptors* , 2001, The Journal of Biological Chemistry.
[246] K. Tracey,et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin , 2000, Nature.
[247] S. Wattler,et al. Structural and phylogenetic characterization of human SLURP‐1, the first secreted mammalian member of the Ly‐6/uPAR protein superfamily , 2008, Protein science : a publication of the Protein Society.
[248] D. Yoshikami,et al. Single-Residue Alteration in α-Conotoxin PnIA Switches Its nAChR Subtype Selectivity† , 1999 .
[249] A. Sali,et al. lynx1, an Endogenous Toxin-like Modulator of Nicotinic Acetylcholine Receptors in the Mammalian CNS , 1999, Neuron.
[250] P. Alewood,et al. α‐Conotoxin ImI Inhibits the α‐Bungarotoxin‐Resistant Nicotinic Response in Bovine Adrenal Chromaffin Cells , 1999 .
[251] G. Cragg. Paclitaxel (Taxol®): A success story with valuable lessons for natural product drug discovery and development , 1998, Medicinal research reviews.
[252] K. Kawashima,et al. Induction of choline acetyltransferase mRNA in human mononuclear leukocytes stimulated by phytohemagglutinin, a T-cell activator , 1998, Journal of Neuroimmunology.
[253] N. Unwin. The Nicotinic Acetylcholine Receptor of theTorpedoElectric Ray , 1998 .
[254] K. Kawashima,et al. Localization and synthesis of acetylcholine in human leukemic T cell lines , 1996, Journal of neuroscience research.
[255] M. Rustici,et al. Binding of HIV‐1 gp120 to the nicotinic receptor , 1992, FEBS letters.
[256] E. Masini,et al. Release of histamine from rat mast cells by acetylcholine , 1978, Nature.
[257] Y. Dupont. X‐ray diffraction study of membrane fragments rich in acetylcholine receptor protein prepared from the electric organ of Torpedo Marmorata , 1974, FEBS letters.